SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-18-031444
Filing Date
2018-02-05
Accepted
2018-02-05 06:16:05
Documents
7
Period of Report
2018-01-31
Items
Item 2.02: Results of Operations and Financial Condition
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d444741d8k.htm 8-K 44664
2 EX-99.1 d444741dex991.htm EX-99.1 22029
3 EX-99.2 d444741dex992.htm EX-99.2 11576
4 EX-99.3 d444741dex993.htm EX-99.3 301168
5 GRAPHIC g444741g65a24.jpg GRAPHIC 163379
6 GRAPHIC g444741g86q17.jpg GRAPHIC 2998
7 GRAPHIC g444741img1.jpg GRAPHIC 8093
  Complete submission text file 0001193125-18-031444.txt   621797
Mailing Address 6200 LOOKOUT ROAD BOULDER CO 80301
Business Address 6200 LOOKOUT ROAD BOULDER CO 80301 303-531-5952
MIRAGEN THERAPEUTICS, INC. (Filer) CIK: 0001590750 (see all company filings)

IRS No.: 471187261 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36483 | Film No.: 18572725
SIC: 8071 Services-Medical Laboratories